RYTM vs TECH
Rhythm Pharmaceuticals Inc (RYTM) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Rhythm Pharmaceuticals Inc (RYTM) is a biotechnology company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported RYTM revenue for 2024-12-31 was $130.1M. Net income was -$260.6M. Revenue was up 68.1% from 2023-12-31 to 2024-12-31. RYTM currently screens at market cap $6.49B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
RYTM currently screens at market cap $6.49B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the RYTM and TECH stock pages for the full models.
Not investment advice.